Laekna doses first subjects in Phase Ib/III breast cancer therapy trial
Laekna Therapeutics has dosed the first two subjects in the US and China, respectively, in...
The patent analytics dashboard provides relevant information on patents in the pharma industry based on GlobalData’s Patents database. It encompasses the global IP landscape, with focus on various major themes, patenting trends, top players, countries, and sectors in the pharma industry.
Laekna Therapeutics has dosed the first two subjects in the US and China, respectively, in...
Bristol-Myers Squibb (BMS) has reported initial assessment results from Phase II PILOT clinical trial, where its Breyanzi (lisocabtagene maraleucel) offered...
NRx Pharmaceuticals has reported that the Data Safety and Monitoring Board (DSMB) of the ACTIV-3b...
The patents tracker provides insights into pharmaceutical patent records, inventions, assignees, inventors, authorities, and locations over the past two decades.
The pharmaceutical patent analytics dashboard provides information about trends in IP protection in the pharma industry. The following chart indicates the filings, grants and all publication trends over the past 20 years.
The patents analytics dashboard tracks heavy IP-protected countries in the world based on GlobalData’s Patents database. The chart shows the number of pharmaceutical patents filed across countries worldwide over the past two decades.
The dashboard tracks pharmaceutical companies holding the most number of patent publications. The following chart lists top assignees by patent publication count in the pharma industry over the past two decades.
The patents analytics dashboard tracks pharmaceutical patent publications by therapeutic area/indication. The chart indicates the top therapy areas/indications in terms of patent publications over the past two decades.
The dashboard tracks the total pharmaceutical patent publications across various themes based on GlobalData’s Patents database. The chart indicates the top themes by patent publication count over the past two decades.
All markets data shared in the dashboard is copyright of GlobalData PLC and is subject to the GlobalData Terms & Conditions. Content in the dashboard should not be viewed as a recommendation and should not be relied upon to make investment decisions. We make every effort to ensure our content is accurate and to correct mistakes as soon as possible. If you spot an error please email editorialenquiries@globaldata.com. Further information about our editorial standards and complaints procedure is available here. GlobalData is not responsible for the use of any content outside the scope of the GlobalData Terms & Conditions.
Cerner Corporation has entered a partnership with Elligo Health Research and Freenome to boost access to clinical trials for cancer. The collaboration will facilitate a clinical trial…
Curebase has raised $40m in a Series B financing round led by Industry Ventures to advance the development of its end-to-end clinical trial execution model. The funding…
Codagenix, in partnership with the Serum Institute of India, has announced the dosing of the first patient in a Phase…
Signant Health has unveiled Oncology Complete, an offering that features complete clinical technology for streamlining modern oncology clinical trials. The…
Aerie Pharmaceuticals has announced the dosing of the first participant in the Phase III clinical trial of AR-15512 ophthalmic solution…
Budgeting is not as glamorous as other aspects of clinical trial operations, yet this back-office task is key to a…